foxo4 dri senolytic peptide human trial 2024 2025 FOXO4-DRI UK | Research Targeting Cellular Senescence in Aging

This is how we deliver care with intention, accountability, and a higher standard than transactional telehealth models

The peptide also promotes polarization of macrophages from pro-inflammatory M1 phenotypes toward tissue-repairing M2 phenotypes, with treated macrophages showing 70% increased phagocytic activity for clearing inflammatory debris and 3-fold higher production of VEGF compared to untreated controls

The question of whether do sermorelin pills work is not a matter of finding the right brand or the right dose

maintenance phase is the heavy draw 26 weeks 13 vials Standard Phase 2 duration 32 weeks 16 vials Phase 2 T2D study duration 68 weeks 30 vials REDEFINE 1 / REDEFINE 2 endpoint duration Peptide Vials (10 mg vial, 2.4 mg/week target) Each 10 mg vial covers about 4 weekly doses at 2.4 mg/week

Orders ship from regional and US supply with a typical dispatch window and tracked delivery